Vontier Reports Fourth Quarter and Full Year 2022 Results; Initiates 2023 Guidance
Go back to Vontier Reports Fourth Quarter and Full Year 2022 Results; Initiates 2023 Guidance| Savient Pharmaceuticals, Inc. (NYSE: VNT) | Delayed: 30.19 -0.04 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.23 | 52 Week High | $9.92 | |||
| Open | $30.19 | 52 Week Low | $9.10 | |||
| Day High | $30.49 | P/E | N/A | |||
| Day Low | $29.92 | EPS | $-0.94 | |||
| Volume | 869,909 | |||||
